In one paragraphArticle in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Noemí CepriánDepartamento de Genética, Fisiología y Microbiología, Facultad de Ciencias Biológicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0001-7028-3083 Irene Martínez de TodaDepartamento de Genética, Fisiología y Microbiología, Facultad de Ciencias Biológicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Paula Jara CaroInstituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), RICORS 2040, 28041 Madrid, Spain.
Claudia YusteInstituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), RICORS 2040, 28041 Madrid, Spain.
Gemma Valera-ArévaloDepartamento de Genética, Fisiología y Microbiología, Facultad de Ciencias Biológicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Ignacio González de PablosDepartamento de Nefrología, Hospital Universitario 12 de Octubre, RICORS 2040, 28041 Madrid, Spain.
Andrea FiguerDepartamento de Biología de Sistemas, Universidad de Alcalá, 28871 Alcalá de Henares, Spain.ORCID 0000-0001-9788-0136 Matilde AliqueDepartamento de Biología de Sistemas, Universidad de Alcalá, 28871 Alcalá de Henares, Spain.ORCID 0000-0002-7912-1133 Rafael RamírezDepartamento de Biología de Sistemas, Universidad de Alcalá, 28871 Alcalá de Henares, Spain.ORCID 0000-0003-4598-339X Enrique MoralesInstituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), RICORS 2040, 28041 Madrid, Spain.ORCID 0000-0002-5824-6973 Julia CarracedoDepartamento de Genética, Fisiología y Microbiología, Facultad de Ciencias Biológicas, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0002-8422-812X Funding
Instituto Salud Carlos III PI17/01029, PI19/00240, PI20/01321, and PI23/01109
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
advanced chronic kidney diseasefrailtyhemodialysisimmune alterationsimmune-fragile profilekidney transplantationmortality riskperitoneal dialysis
Identifiers
PMID41153657
PMCPMC12561049
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390